Neovac Ltd

Neovac Ltd, based in Abingdon, UK, is a small, active company founded three years ago. With 15 employees and £4,402,054 in assets, it’s a relatively modest operation overseen by nine directors and one owner, Peer Dan. The company imports optical and medical tools and devices, though its import activity has been irregular, with just two months of imports recorded in the last year.

The company’s website reveals a more ambitious focus: developing next-generation lipid nanoparticles (LNPs) for RNA technology. Neovac positions itself as a clinical-stage company aiming to revolutionize mRNA vaccines and treatments. It's clearly targeting a high-value market, emphasizing precision targeting of organs and tissues to unlock new possibilities in disease treatment. The company’s experienced team, combining nanotechnology, precision medicine, and RNA-based drug delivery, suggests a focus on innovation and scientific expertise.

Financially, Neovac Ltd presents a mixed picture. While cash bank holdings increased significantly by 120%, jumping to £3.3 million, other indicators raise concerns. Creditors have ballooned dramatically, reaching £11 million, and trade debtors have surged by an astonishing 1,200%, indicating potential difficulties in collecting payments. Net assets, however, decreased by 7.9% to -£7.8 million. Despite these challenges, the company’s fixed assets decreased by 11%, and depreciation charges have remained consistent. Future minimum lease payments are expected to increase, and the company is actively pursuing funding plans. No auditor is mentioned, which is common for small companies.

Overall, Neovac Ltd appears to be a high-risk, high-reward venture. While it has secured significant cash reserves and is pursuing cutting-edge technology, the rapid growth in liabilities suggests it’s burning through money quickly. Whether it can secure further funding and successfully commercialize its LNP platform remains to be seen, but the company’s focus on innovation and its experienced team offer some hope.

Registered in England/Wales under the registration number 13606487, with a registered address at OX14 4SA, England, Abingdon, Suites 1 And 2 127 Olympic Avenue, Milton Park.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.